Algert Global’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.56M | Buy |
149,910
+73,241
| +96% | +$1.25M | 0.05% | 556 |
|
2025
Q1 | $4.89M | Buy |
76,669
+1,685
| +2% | +$108K | 0.12% | 283 |
|
2024
Q4 | $9.12M | Buy |
74,984
+5,778
| +8% | +$703K | 0.21% | 134 |
|
2024
Q3 | $8.64M | Buy |
69,206
+6,654
| +11% | +$831K | 0.23% | 108 |
|
2024
Q2 | $9.88M | Buy |
62,552
+795
| +1% | +$126K | 0.33% | 44 |
|
2024
Q1 | $8M | Buy |
61,757
+15,238
| +33% | +$1.97M | 0.31% | 64 |
|
2023
Q4 | $4.49M | Buy |
46,519
+3,337
| +8% | +$322K | 0.18% | 169 |
|
2023
Q3 | $5.24M | Buy |
43,182
+17,670
| +69% | +$2.14M | 0.25% | 105 |
|
2023
Q2 | $2.92M | Buy |
25,512
+4,480
| +21% | +$513K | 0.13% | 253 |
|
2023
Q1 | $2.9M | Sell |
21,032
-31,212
| -60% | -$4.3M | 0.14% | 226 |
|
2022
Q4 | $6.77M | Sell |
52,244
-8,426
| -14% | -$1.09M | 0.38% | 28 |
|
2022
Q3 | $6.71M | Buy |
60,670
+17,479
| +40% | +$1.93M | 0.41% | 10 |
|
2022
Q2 | $3.24M | Sell |
43,191
-3,812
| -8% | -$286K | 0.24% | 70 |
|
2022
Q1 | $3.67M | Buy |
47,003
+33,066
| +237% | +$2.58M | 0.24% | 78 |
|
2021
Q4 | $1.26M | Hold |
13,937
| – | – | 0.16% | 206 |
|
2021
Q3 | $1.29M | Buy |
+13,937
| New | +$1.29M | 0.17% | 148 |
|
2020
Q3 | – | Sell |
-6,138
| Closed | -$984K | – | 480 |
|
2020
Q2 | $984K | Buy |
+6,138
| New | +$984K | 0.33% | 106 |
|